A new UCLA study has found that artificial intelligence could help doctors identify prostate cancer patients most ...

Scientists at the UCLA Health Jonsson Comprehensive Cancer Center and the University of Toronto have revealed how a tiny ...

Scientists at the UCLA Health Jonsson Comprehensive Cancer Center and the University of Toronto have revealed how a tiny chemical modification in RNA, known as m6A, plays a critical role in the ...

"This study offers a new way of thinking about prostate cancer risk assessment," said Boutros, who also serves as the interim vice dean for research at the David Geffen School of Medicine at UCLA ...

A study led by UCLA investigators shows that artificial intelligence (AI) could play a key role in improving treatment outcomes for men with prostate cancer by helping physicians determine who is most ...

Scientists from UCLA, the University of Toronto and the University of Melbourne have uncovered new genetic clues that explain why some prostate cancers remain slow-growing while others become ...

A recent study suggests that using artificial intelligence to measure tumor size could reduce treatment failures by more than 70%.

He’s the executive vice chair of radiation oncology at the David Geffen School of Medicine at UCLA and co-first ... used radiotherapy regimen for prostate cancer. However, there are ongoing ...

A study led by UCLA investigators shows that artificial intelligence (AI) could play a key role in improving treatment outcomes for men with prostate cancer by helping physicians determine who is ...

A new artificial intelligence tool could help doctors determine which prostate cancer patients are most likely to benefit ...

Scientists at the UCLA Health Jonsson Comprehensive Cancer Center and the University of Toronto have revealed how a tiny chemical modification in RNA, known as m6A, plays a critical role in the ...